Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) has the poorest prognosis of all breast cancer subtypes and is one of the most fatal diseases for women. Combining cytotoxic chemotherapy with immunotherapy has shown great promise for TNBC treatment. However, chemotherapy often leads to the developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Shen-Jun, Xu, Yong-Hong, Wang, Chao, An, Hui-Chao, Xu, Hua-Zhen, Li, Ke, Komatsu, Naoki, Zhao, Li, Chen, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798483/
https://www.ncbi.nlm.nih.gov/pubmed/31623629
http://dx.doi.org/10.1186/s12951-019-0541-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798483/
https://www.ncbi.nlm.nih.gov/pubmed/31623629
http://dx.doi.org/10.1186/s12951-019-0541-8

Ejemplares similares